CNBC.com |
Pfizer 6.5B offer 'inadequate': AstraZeneca
CNBC.com American pharmaceutical giant Pfizer has hiked its takeover bid for British rival AstraZeneca to 6.5 billion. CNBC's Catherine Boyle reports. AstraZeneca's board rejected a 6.5 billion bid from predator Pfizer just hours after it was received, arguing that it … AstraZeneca Rejects Pfizer Bid AstraZeneca rejects Pfizer's £63bn new offer UPDATE 5-AstraZeneca rejects Pfizer's raised bid of 6 bln |